The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice
Open accessAbstract
BACKGROUND: Sepsis is defined as end-organ dysfunction resulting from the host's inflammatory response to infection. One of the most common sepsis-injured organs is the kidneys, resulting in acute kidney injury (AKI) that contributes to the high morbidity and mortality, especially patients in the intensive care unit. Fisetin, a naturally occurring flavonoid, has been reported to protect against the rat of lipopolysaccharide (LPS)-induced acute lung injury. However, the effect of fisetin on septic AKI remains unknown. PURPOSE: The current study proposed to systematically investigate the renoprotective effects and the underlying mechanisms of fisetin in septic AKI mice. METHODS: The model of septic AKI was established on male C57BL/6 J mice by a single intraperitoneal injection of LPS (10 mg/kg). Fisetin was administrated by gavage at 100 mg/kg for 3 consecutive days before LPS injection and the mice were sacrificed at 16 h after LPS injection. The serum and kidney samples were evaluated for biochemical analysis, histopathological examinations as well as inflammation and apoptosis related gene/protein expression. RESULTS: Pretreatment with fisetin significantly alleviated the elevated levels of serum creatinine and blood urea nitrogen in LPS-treated mice. Consistently, LPS induced renal damage as implied by histopathological score and the increased injury markers NGAL and KIM-1, which was attenuated by fisetin. Meanwhile, LPS injection triggered proinflammatory cytokine production and inflammation related proteins in the kidneys. However, fisetin inhibited renal expression of IL-6, IL-1β, TNF-α, HMGB1, iNOS and COX-2 to improve inflammatory response. Furthermore, fisetin effectively reduced the number of TUNEL positive apoptotic cells and suppressed apoptotic protein of Bcl-2, BAX and cleaved caspase-3 in the kidneys of LPS-induced septic AKI. Mechanistically, LPS stimulated the expression of TLR4 and the phosphorylation of NF-κB p65, MAPK (p38, ERK1/2 and JNK), Src and AKT in the injured kidneys, while fisetin notably suppressed the corresponding protein expression. CONCLUSION: Fisetin alleviated kidney inflammation and apoptosis to protect against LPS-induced septic AKI mice via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peerapornratana, S., Manrique-Caballero, C. L., Gómez, H., & Kellum, J. A. (2019) · Kidney International · doi:10.1016/j.kint.2019.05.026 · Cited by 1,471
Fisetin is a senotherapeutic that extends health and lifespan
Yousefzadeh, M. J., Zhu, Y., McGowan, S. J., Angelini, L., Fuhrmann-Stroissnigg, H., Xu, M., Ling, Y. Y., Melos, K. I., Pirtskhalava, T., Inman, C. L., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.09.015 · Cited by 1,032
Sepsis definitions: time for change
Vincent, J.-L., Opal, S. M., Marshall, J. C., & Tracey, K. J. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61815-7 · Cited by 734
Sepsis-induced acute kidney injury
Gómez, H., & Kellum, J. A. (2016) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000356 · Cited by 312
Sahu, B. D., Kalvala, A. K., Koneru, M., Mahesh Kumar, J., Kuncha, M., Rachamalla, S. S., & Sistla, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105070 · Cited by 194
Lee, J.-D., Huh, J.-E., Jeon, G., Yang, H.-R., Woo, H.-S., Choi, D.-Y., & Park, D.-S. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2008.11.005 · Cited by 180
Dellepiane, S., Marengo, M., & Cantaluppi, V. (2016) · Critical Care · doi:10.1186/s13054-016-1219-3 · Cited by 162
Fisetin and Its Role in Chronic Diseases
Pal, H. C., Pearlman, R. L., & Afaq, F. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-41334-1_10 · Cited by 126
A review on the chemotherapeutic potential of fisetin: In vitro evidences
Sundarraj, K., Raghunath, A., & Perumal, E. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.164 · Cited by 125
Prasath, G. S., & Subramanian, S. P. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.07.021 · Cited by 120
Cited by
Zhao, P., Li, X., Yang, Q., Lu, Y., Wang, G., Yang, H., Dong, J., & Zhang, H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1038802 · Cited by 43
Chen, L., Qing, W., Yi, Z., Lin, G., Peng, Q., & Zhou, F. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.701760 · Cited by 31
Battaglia-Vieni, A., Marchant, V., Tejedor-Santamaria, L., García-Caballero, C., Flores-Salguero, E., Ruiz-Torres, M. P., Rayego-Mateos, S., Sanz, A. B., Ortiz, A., & Ruiz-Ortega, M. (2025) · Pharmaceuticals · doi:10.3390/ph18060822 · Cited by 6
Metadata
- Authors
- Ren, Q., Guo, F., Tao, S., Huang, R., Ma, L., & Fu, P.
- Venue
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 122
- Pages
- 109772
- ISSN
- 0753-3322 (ISSN-L)
- OpenAlex
- W2996969437
- Cited by
- 424
- References
- 27
- FWCI
- 18.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice. https://app.cochat.ai/papers/10.1016/j.biopha.2019.109772
- The paper
- Ren, Q., Guo, F., Tao, S., Huang, R., Ma, L., & Fu, P. (2020). Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2019.109772
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.